COVID-19 and hepatorenal syndrome.

Wu, Henry H L; Athwal, Varinder S; Kalra, Philip A; Chinnadurai, Rajkumar

Wu, Henry H L; Athwal, Varinder S; Kalra, Philip A; Chinnadurai, Rajkumar.

Affiliation

Wu HHL; Renal Research, Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney 2065, New South Wales, Australia. honlinhenry.wu@health.nsw.gov.au.
Athwal VS; Faculty of Biology, Medicine & Health (Division of Diabetes, Metabolism & Gastroenterology), The University of Manchester, Manchester M13 9PL, United Kingdom.
Kalra PA; Department of Renal Medicine, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, United Kingdom.
Chinnadurai R; Department of Renal Medicine, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, United Kingdom.

World J Gastroenterol ; 28(39): 5666-5678, 2022 Oct 21.

Article in En | MEDLINE | ID: mdl-36338894

Subject(s)

COVID-19; Hepatorenal Syndrome; Liver Diseases; Humans; Hepatorenal Syndrome/epidemiology; Hepatorenal Syndrome/etiology; Hepatorenal Syndrome/therapy; COVID-19/complications; Pandemics; Liver Diseases/epidemiology; Liver Diseases/therapy; Liver Diseases/complications; COVID-19 Drug Treatment

Key words

COVID-19; Clinical assessment; Hepatorenal syndrome; Management; Pathophysiology; Prognosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatorenal Syndrome / COVID-19 / Liver Diseases Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: World J Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Affiliation country: Australia Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google